Answers are grounded in this paper and cite their sources.
We demonstrate the value of reporting probability of false-positive results, probability of false-negative results, and costs to patients and health care. These risk metrics can be calculated from the risk drivers of PPA and PNA combined with estimates of prevalence, cost, and Reff number (people infected by 1 positive SARS-CoV-2 carrier).
No takes yet. Share an insight, caveat, or question.
Brooks et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: